116 related articles for article (PubMed ID: 18087819)
41. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
Ueda K; Kato Y; Komatsu K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
[TBL] [Abstract][Full Text] [Related]
42. Transport studies with 5-aminosalicylate.
Xin HW; Schwab M; Klotz U
Eur J Clin Pharmacol; 2006 Oct; 62(10):871-5. PubMed ID: 16944117
[TBL] [Abstract][Full Text] [Related]
43. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
Johnson DR; Habeebu SS; Klaassen CD
Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
[TBL] [Abstract][Full Text] [Related]
44. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2).
Berger V; Gabriel AF; Sergent T; Trouet A; Larondelle Y; Schneider YJ
Toxicol Lett; 2003 Apr; 140-141():465-76. PubMed ID: 12676495
[TBL] [Abstract][Full Text] [Related]
45. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
46. Probenecid-induced effects on bile flow and biliary excretion of 3H-ouabain.
Erttmann RR; Damm KH
Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):96-106. PubMed ID: 999406
[TBL] [Abstract][Full Text] [Related]
47. Transport characteristics of fexofenadine in the Caco-2 cell model.
Petri N; Tannergren C; Rungstad D; Lennernäs H
Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
[TBL] [Abstract][Full Text] [Related]
48. Disruption of function and localization of tight junctional structures and Mrp2 in sustained estradiol-17beta-D-glucuronide-induced cholestasis.
Mottino AD; Hoffman T; Crocenzi FA; Sánchez Pozzi EJ; Roma MG; Vore M
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G391-402. PubMed ID: 17463180
[TBL] [Abstract][Full Text] [Related]
49. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
[TBL] [Abstract][Full Text] [Related]
50. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
[TBL] [Abstract][Full Text] [Related]
51. Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells.
Yunomae K; Arima H; Hirayama F; Uekama K
FEBS Lett; 2003 Feb; 536(1-3):225-31. PubMed ID: 12586368
[TBL] [Abstract][Full Text] [Related]
52. Hepatic uptake and biliary excretion of the neuroprotectant 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)-quinoxaline in rat liver. Involvement of an organic anion transport system.
Hansen KT
Biochem Pharmacol; 1995 Feb; 49(4):489-93. PubMed ID: 7872954
[TBL] [Abstract][Full Text] [Related]
53. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Hirouchi M; Suzuki H; Sugiyama Y
Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
[TBL] [Abstract][Full Text] [Related]
54. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells.
Henry C; Vitrac X; Decendit A; Ennamany R; Krisa S; Mérillon JM
J Agric Food Chem; 2005 Feb; 53(3):798-803. PubMed ID: 15686436
[TBL] [Abstract][Full Text] [Related]
55. Dramatic increase in hepatic and biliary curcumin exposure by modulation of its elimination pathway in rats.
Lee JH; Kim HG; Oh JH; Lee YJ
J Pharm Pharmacol; 2013 Mar; 65(3):423-9. PubMed ID: 23356851
[TBL] [Abstract][Full Text] [Related]
56. Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2.
Sasaki M; Suzuki H; Aoki J; Ito K; Meier PJ; Sugiyama Y
Mol Pharmacol; 2004 Sep; 66(3):450-9. PubMed ID: 15322236
[TBL] [Abstract][Full Text] [Related]
57. Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2).
Jäger W; Gehring E; Hagenauer B; Aust S; Senderowicz A; Thalhammer T
Life Sci; 2003 Oct; 73(22):2841-54. PubMed ID: 14511769
[TBL] [Abstract][Full Text] [Related]
58. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats.
Naruhashi K; Tamai I; Inoue N; Muraoka H; Sai Y; Suzuki N; Tsuji A
Antimicrob Agents Chemother; 2002 Feb; 46(2):344-9. PubMed ID: 11796340
[TBL] [Abstract][Full Text] [Related]
59. [Tubular transporters OAT1 and MRP2 and clearance of adefovir].
Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
Nephrol Ther; 2005 Nov; 1(5):296-300. PubMed ID: 16895698
[TBL] [Abstract][Full Text] [Related]
60. Effect of hesperidin on the pharmacokinetics of CPT-11 and its active metabolite SN-38 by regulating hepatic Mrp2 in rats.
Wang X; Rao Z; Qin H; Zhang G; Ma Y; Jin Y; Han M; Shi A; Wang Y; Wu X
Biopharm Drug Dispos; 2016 Oct; 37(7):421-432. PubMed ID: 27510985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
